f38c5f85071843aa9b2ac49b648ea256
HURO PATH Lysis solution (Hemolics)
CELLTRAZONE CO., LTD.·I·Ecuador ARCSA·Registered December 07, 2022
Device classification
- Risk class
- I
- Product type
- In Vitro Diagnostic
- Brand name
- CelltraZone
- Commercial name
- 19-633 IVD Reagents/Kits, Cytology/Histology, Stains, Solution
- Sterilization method
- METHODOLOGY: HISTOCHEMISTRY AND CYTOCHEMISTRY
Registration information
- Analysis ID
- f38c5f85071843aa9b2ac49b648ea256
- Registration date
- December 07, 2022
- Expiration date
- December 07, 2027
- Creation date
- July 12, 2022
Manufacturer
- City
- GIMPO-SI
- Country
- KOREA, REPUBLIC OF
- Address
- 1FLOOR, 6FLOOR, 16, ARAYUK-RO, GOCHON-EUP, GIMPO-SI, GYEONGGI-DO, REPUBLICA DE KOREA
Product owner
- Name
- CELLTRAZONE CO., LTD.
- Country
- KOREA, REPUBLIC OF
Authorized representative
- Address
- LUIS MORENO MORA AND FRANCISCO MOSCOSO
- Phone
- 2818889
Product use
SOLUCION ACCESORIA PARA HURO PATH SOLUTION (GYN) Y HURO PATH SOLUTION (NO-GYN)
About this record
Access comprehensive regulatory information for HURO PATH Lysis solution (Hemolics) in the Ecuador medical device market through Pure Global AI's free database. This I medical device is registered under ARCSA ID f38c5f85071843aa9b2ac49b648ea256 and manufactured by CELLTRAZONE CO., LTD.. The device was registered on December 07, 2022.
This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.